We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IKT icon
3501
Inhibikase Therapeutics
IKT
$342M
$279K ﹤0.01%
31,412
-2,121
-6% -$17.1K
TUYA
3502
Tuya Inc
TUYA
$1.03B
$279K ﹤0.01%
+94,300
New +$452K
AMOV
3503
DELISTED
America Movil SAB de CV
AMOV
$278K ﹤0.01%
13,253
FBRX icon
3504
Forte Biosciences
FBRX
$1.57B
$277K ﹤0.01%
+7,576
New +$287K
NSSC icon
3505
Napco Security Technologies
NSSC
$1.32B
$277K ﹤0.01%
13,500
-28,900
-68% -$600K
PRLD icon
3506
Prelude Therapeutics
PRLD
$366M
$277K ﹤0.01%
40,100
-87,100
-68% -$797K
SQFT icon
3507
Presidio Property Trust
SQFT
$277K ﹤0.01%
7,455
-772
-9% -$29K
AVEO
3508
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$277K ﹤0.01%
+49,600
New +$204K
CARM
3509
DELISTED
Carisma Therapeutics
CARM
$276K ﹤0.01%
+22,872
New +$319K
KTCC icon
3510
Key Tronic
KTCC
$42.8M
$276K ﹤0.01%
48,900
-17,875
-27% -$107K
VBK icon
3511
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$273K ﹤0.01%
1,100
-1,535
-58% -$378K
XCUR icon
3512
Exicure
XCUR
$10.2M
$273K ﹤0.01%
9,130
-12,531
-58% -$385K
RPAR icon
3513
RPAR Risk Parity ETF
RPAR
$570M
$272K ﹤0.01%
11,477
-2,223
-16% -$53.3K
CTSO icon
3514
Cytosorbents Corp
CTSO
$22.7M
$271K ﹤0.01%
+84,900
New +$304K
LYEL icon
3515
Lyell Immunopharma
LYEL
$317M
$270K ﹤0.01%
+2,675
New +$324K
PATI
3516
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$270K ﹤0.01%
33,808
-4,801
-12% -$39.2K
BIOC
3517
DELISTED
Biocept, Inc.
BIOC
$270K ﹤0.01%
3,880
+827
+27% +$65K
STXS icon
3518
Stereotaxis
STXS
$126M
$269K ﹤0.01%
+72,100
New +$340K
KNTE
3519
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$269K ﹤0.01%
+23,900
New +$263K
BXSL icon
3520
Blackstone Secured Lending
BXSL
$5.37B
$268K ﹤0.01%
+9,600
New +$281K
WINT
3521
DELISTED
Windtree Therapeutics
WINT
$267K ﹤0.01%
5
AVTX icon
3522
Avalo Therapeutics
AVTX
$965M
$266K ﹤0.01%
127
+113
+807% +$284K
BIRD icon
3523
Smartbird Inc
BIRD
$19.5M
$266K ﹤0.01%
+2,211
New +$435K
HPK icon
3524
HighPeak Energy
HPK
$903M
$266K ﹤0.01%
+12,000
New +$236K
OVID icon
3525
Ovid Therapeutics
OVID
$414M
$266K ﹤0.01%
84,800
+26,200
+45% +$82.4K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.